Despite languishing, pharma among top bets for DSP MF: Vinit Sambre
Despite being a defensive bet, pharmaceutical stocks have languished in 2022 primarily because of challenges like the poor pricing environment in the US, cross-currency fluctuations,…
Read More...
Read More...